Corporate News     03-Nov-22 Renaissance Global to hold board meeting On 9 November 2022 Renaissance Global will hold a meeting of the Board of Directors of the Company on 9 November 2022. Previous News   Renaissance Global consolidated net profit rises 39.33% in the March 2022 quarter  ( Results - Announcements 01-Jun-22   08:12 )   Renaissance Global announces board meeting date  ( Corporate News - 19-Oct-24   10:15 )   Renaissance Global consolidated net profit rises 42.75% in the June 2019 quarter  ( Results - Announcements 14-Aug-19   16:06 )   Renaissance Global to convene AGM  ( Corporate News - 09-Aug-24   16:22 )   Renaissance Jewellery consolidated net profit declines 27.27% in the December 2016 quarter  ( Results - Announcements 11-Feb-17   10:46 )   Renaissance Global standalone net profit rises 14.68% in the December 2019 quarter  ( Results - Announcements 12-Feb-20   16:58 )   Renaissance Jewellery consolidated net profit rises 183.80% in the September 2015 quarter  ( Results - Announcements 31-Oct-15   10:09 )   Renaissance Global to convene board meeting  ( Corporate News - 03-Feb-24   14:14 )   Board of Renaissance Global recommends interim dividend  ( Corporate News - 08-Feb-22   11:12 )   Renaissance Global acquires assets of US-based jewellery maker - Four Mine Inc  ( Corporate News - 24-Feb-22   14:48 )   Renaissance Jewellery standalone net profit rises 24.19% in the September 2015 quarter  ( Results - Announcements 31-Oct-15   09:00 )	Other Stories   Religare Enterprises allots 3.10 lakh equity shares under ESOP   04-Dec-24   18:49   Winsome Yarns to convene AGM   04-Dec-24   18:08   Mandeep Auto Industries to convene AGM   04-Dec-24   18:08   Ipca Laboratories to voluntarily close its wholly owned subsidiary in Mexico   04-Dec-24   16:57   Sonata Software achieves AWS Generative AI Competency   04-Dec-24   16:56   Nuvama Wealth Management allots 10,256 equity shares under ESOS   04-Dec-24   16:54   IndiaMART Intermesh allots 53,000 equity shares under ESOP   04-Dec-24   16:45   Alembic Pharma receives USFDA's tentative approval for Olopatadine Hydrochloride Ophthalmic Solution   04-Dec-24   16:41   Uno Minda announces change in senior management   04-Dec-24   16:40   Cyient allots 26,604 equity shares under ASOP   04-Dec-24   16:39
Back Top